PerkinElmer Gets ViaCord Stem Cell Preserver In $300 Mil. ViaCell Deal
This article was originally published in The Gray Sheet
Executive Summary
Health sciences giant PerkinElmer will expand its neonatal offerings with its $300 million acquisition of ViaCell, announced Oct. 1